← Evidence map

ArticlePloS one2026

Retraction: Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Retraction: Phospho-Aspirin-2 (MDC-22) Inhibits Estrogen Receptor Positive Breast Cancer Growth Both In Vitro and In Vivo by a Redox-Dependent Effect. | OpenQuestion